PARIS: Gay men at high risk of contracting HIV should have access to a daily dose of a drug used to treat the AIDS-causing virus, but as a preventive measure, researchers recommended Thursday.
The medicine, sold under the brand name Truvada, proved almost 90 percent effective at protecting men taking part in a British study, they wrote in The Lancet medical journal.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.